Smit T, Koornneef L
Orbita Zentrum, Akademisch Medisch Zentrum, University, Amsterdam.
Fortschr Ophthalmol. 1990;87(5):533-6.
A retrospective study was performed on 114 patients who had received an intraorbital ball implant after removal of an eye: 44 had a primary implant inserted at the time of enucleation and 70 a secondary implant, inserted at a later date. We observed distinct advantages in the primary implantation group. Patients with a primary implant, an acrylic ball covered with sclera inserted within Tenon's capsule, had better cosmetic results and a lower complication rate and fewer needed any other therapeutic measures. Of the patients with primary implants 89% did not require further treatment, as against 51% with secondary implants.
对114例眼球摘除术后接受眶内球植入的患者进行了一项回顾性研究：44例在眼球摘除时植入了一期植入物，70例在稍后时间植入了二期植入物。我们观察到一期植入组有明显优势。接受一期植入物（将覆盖巩膜的丙烯酸球植入Tenon囊内）的患者美容效果更好，并发症发生率更低，且较少需要任何其他治疗措施。接受一期植入物的患者中，89%不需要进一步治疗，而接受二期植入物的患者这一比例为51%。
